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Abstract
Background: The transcription/export complex is evolutionarily conserved from yeast to man and is required
for coupled transcription elongation and nuclear export of mRNAs. FMIP(Fms interacting protein) is a member
of the THO (suppressors of the transcriptional defects of hpr1delta by overexpression) complex which is a
subcomplex of the transcription/export complex. THO complex (THOC) components are not essential for bulk
poly (A)+ RNA export in higher eukaryotes, but for the nuclear export of subset of mRNAs, however, their exact
role is still unclear.
Results: To study the role of THOC5/Fms interacting protein in vivo, we generated THOC5/Fms interacting
protein knockout mice. Since these mice are embryonic lethal, we then generated interferon inducible conditional
THOC5/Fms interacting protein knockout mice. After three poly injections all of the mice died within 14 days.
No pathological alterations, however, w e r e  o b s e r v e d  i n  l i v e r ,  k i d n e y  o r  h e a r t .  T h u s  w e  c o n s i d e r e d  t h e
hematopoietic system and found that seven days after poly injection, the number of blood cells in peripheral blood
decreased drastically. Investigation of bone marrow cells showed that these became apoptotic within seven days
after poly injection. Committed myeloid progenitor cells and cells with long term reconstituting potential were
lost from bone marrow within four days after poly injection. Furthermore, infusion of normal bone marrow cells
rescued mice from death induced by loss of THOC5/Fms interacting protein.
Conclusion: THOC5/Fms interacting protein is an essential element in the maintenance of hematopoiesis.
Furthermore, mechanistically depletion of THOC5/Fms interacting protein causes the down-regulation of its
direct interacting partner, THOC1 which may contribute to altered THO complex function and cell death.
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Background
During expression of protein-coding genes, pre-mRNAs
are transcribed in the nucleus and undergo several RNA-
processing steps. The mature mRNA is then exported from
the nucleus to the cytoplasm for translation. Nuclear
export of mRNA composes one part of a larger network of
molecular events that begin with transcription of the
mRNA in the nucleus and end with its translation and
degradation in the cytoplasm. The TREX (transcription/
export) complex is conserved in evolution from yeast to
man and is required for coupled transcription elongation
and nuclear export of mRNAs [1-4]. The TREX complex in
mammals and Drosophila is composed of the THO (sup-
pressors of the transcriptional defects of hpr1delta by
overexpression) subcomplex (THO-complex 1 (THOC1)
1, THOC2, THOC5, THOC6 and THOC7), THOC3,
UAP56 and Aly/THOC4 [5,6]. However, the THO com-
plex components are not essential for bulk poly (A) + RNA
export in higher eukaryotes [7-10]. Furthermore, the
nuclear export of only a subset of mRNAs is affected by
depletion of a member of the THO complex [5,10]. These
data suggest that various nuclear mRNA export pathways,
which may be indicated by different adaptor RNA binding
proteins, exist in higher eukaryotes. Recent data show that
Aly and THOC5 function in the tip associating protein
(TAP)-p15 mediated nuclear export of Hsp70 mRNA [11].
It was demonstrated that the depletion of THOC5 does
not affect bulk poly (A)+ RNA export, but does affect
Hsp70 mRNA export in Hela cells. Interestingly, the dele-
tion of THOC1, a major conserved component of THO
complex, causes apoptosis in transformed cells, but not in
normal fibroblasts [12]. Furthermore, the embryonic
development of the conventional THOC1 knockout mice
is arrested around the time of implantation [13], suggest-
ing that the THO complex may play an essential role in
early development.
Fms interacting protein (FMIP) was originally identified
as a substrate for the Macrophage Colony Stimulating Fac-
tor (M-CSF) receptor tyrosine kinase, Fms [14]. FMIP has
been demonstrated to be a member of THO complex,
THOC5 [5,6]. We have previously shown that depletion
of THOC5/FMIP by siRNA or ectopic expression causes
abnormal hematopoiesis and abnormal adipocyte differ-
entiation in myeloid progenitor or mesenchymal progen-
itor cell lines, indicating that the THO-complex is
essential for the differentiation process in mammals [14-
17].
In this study we show that THOC5/FMIP is essential at an
early stage of murine development. Furthermore, using
interferon inducible THOC5/FMIP knockout mice we
demonstrated that this gene is essential for survival. In
these mice, bone marrow and spleen cells became apop-
totic, hematopoietic progenitor cell numbers collapsed
and the animals became anemic. Although the THOC5/
FMIP gene was deleted in liver, kidney, and heart, patho-
logical alterations to these organs were not observed. Fur-
thermore, 9 out of 14 THOC5/FMIP depleted mice
survived over two months by normal bone marrow cell
transplantation with no apparent symptoms.
Results
THOC5/FMIP is essential at an early stage of mouse 
development
To examine the role of THOC5/FMIP in vivo, we first gen-
erated a floxed THOC5/FMIP allele (THOC5/FMIP flox)
by recombination in embryonic stem (ES) cells [18].
Given that the THOC5/FMIP gene spans 20 exons in a
33,523 kb region on chromosome 11, we adopted a tar-
geting strategy where, by flanking exons IV and V with
loxP sites, we could inactivate THOC5/FMIP in a condi-
tional manner (Figure 1A). The deletion of exons IV/V of
THOC5/FMIP causes a frame shift of product and the
truncated protein is expected to be only 83 amino acids
long and lacking the THOC1 binding domain [19]. ES
cells were used to establish a THOC5/FMIP flox strain
(Figure 1A and 1B). Homozygous THOC5/FMIP (flox/
flox) mice were fertile and did not display any phenotypic
or histological abnormalities, showing that the two loxP
sites in the THOC5/FMIP flox locus did not affect its func-
tion. First, we bred THOC5/FMIP floxed mice to EIIa-Cre
mice in which Cre is ubiquitously expressed [20]. After
generation of heterozygote mice (F1), we bred F1 mice
and generated F2 mice. We did not detect any THOC5/
FMIP-/- newborn mice from F2 mice. In addition, the gen-
otype of 59 embryos collected between E5.5 and E8.5 was
determined by the exon IV/V specific PCR analysis of
genomic DNA. Of 59 embryos which we examined, none
was THOC5/FMIP-/- indicating that loss of THOC5/FMIP
causes embryonic lethality before E5.5. Among 59
embryos, 18 were THOC5/FMIP +/+ and 41 were +/-
which was the expected Mendelian ratio (P < 0.0001 by
Chi squared test). THOC5/FMIP +/- mice were indistin-
guishable from wild type.
To examine THOC5/FMIP depletion in adult mice,
THOC5/FMIP (flox/flox) and cre-deleter mice expressing
cre-recombinase (cre) under the control of the interferon-
inducible Mx promoter (Mx-cre) [21] were crossed to
obtain animals that carry the THOC5/FMIP(flox/flox)
allele and Mx-cre gene (Mx-cre THOC5/FMIP (flox/flox)).
THOC5/FMIP expression is reduced in specific organs
The deletion mutation of THOC5/FMIP was induced by
poly (I:C) injection. We first injected six-week-old Mx-cre
THOC5/FMIP (flox/flox) (n = 6) with 250 μg of poly (I:C)
three times, at two to three day intervals. Mx-cre THOC5/
FMIP (flox/flox) mice (two mice each) were sacrificed
before and two (one × poly (I:C) injection), four (two ×BMC Biology 2010, 8:1 http://www.biomedcentral.com/1741-7007/8/1
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Generation of THOC5/FMIP (flox/flox) and Mx-cre THOC5/FMIP (flox/flox) mice Figure 1
Generation of THOC5/FMIP (flox/flox) and Mx-cre THOC5/FMIP (flox/flox) mice. (A) The genomic structure of 
the 33,523 kb THOC5/FMIP locus is depicted. THOC5/FMIP deficient mice were generated using a genomic DNA fragment 
containing exons II, III, IV, and V isolated from 129/ola genetic background. The targeting vector was constructed from a 3.9 kb 
PCR fragment and an adjacent 2.2 kb fragment harboring exons IV/V. Fragments were introduced into the pPNTloxPneo vec-
tor via NotI, XhoI restriction sites and KpnI, respectively. An additional loxP site was inserted into the SacI site downstream of 
exon V: (B) After transfection, ES cell clones carrying the inserted floxed neo cassette and floxed Fmip exons IV/V were iden-
tified by the presence of an 1.9 kb BamHI restriction fragment in Southern Blot analysis with external 3'probe ((*) THOC5/
fmip neo flox/flox). (C) Mx-cre THOC5/FMIP (flox/flox) were sacrificed before (zero day) and after two (one × poly (I:C) 
injection), four (two × poly (I:C) injection) and seven (three × poly (I:C) injection) days after the first poly (I:C) injection and 
genomic DNAs were extracted from liver, spleen, and bone marrow. Genomic DNAs were supplied for the deletion of exons 
IV/V determined by PCR using 5'-TGCTGGCATTGAACTGTG-3' and 5'-CAGCACTGGAGCGGGAGATGT-3'. PCR prod-
uct: wild type allel: 1110 bp; THOC5/FMIP del allele: 355 bp.BMC Biology 2010, 8:1 http://www.biomedcentral.com/1741-7007/8/1
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poly (I:C) injection) and seven (three × poly (I:C) injec-
tion) days after the first poly (I:C) injection and genomic
DNAs were extracted from liver, spleen and bone marrow.
Genomic DNAs were used for the determination of exon
IV/V deletion by PCR using 5'-TGCTGGCATTGAACTGTG-
3' and 5'-CAGCACTGGAGCGGGAGATGT-3' (Figure 1C).
To our surprise, PCR product lacking exons VI/V (355 bp)
was detected in all organs after one × poly (I:C) injection
in all cases (Figure 1C).
Then, we injected six-week-old Mx-cre THOC5/FMIP
(flox/flox) (n = 8) and control THOC5/FMIP(flox/flox) (n
= 6) mice with 250 μg of poly (I:C) three times, at two to
three days intervals. Mx-cre THOC5/FMIP (flox/flox) (n =
4 each) and control THOC5/FMIP(flox/flox) (n = 3 each)
mice were sacrificed at four and seven days after the first
poly (I:C) injection and proteins were extracted from
liver, spleen, kidney, lung, intestine, testicles and bone
marrow. It has been reported that the treatment of the
interferon mediated Cre-inducible mice with poly (I:C)
causes deletion of the target gene only in particular
organs, such as liver and spleen, and to a lesser extent in
heart and kidney [21].
We examined, therefore, the THOC5/FMIP protein level
in liver, spleen, kidney, lung, intestine, testicles and bone
marrow using THOC5/FMIP specific antibody and west-
ern blot [16]. After poly (I:C) injection, the level of
THOC5/FMIP is reduced by approximately 80% in liver
(P < 0.0001), kidney (P = 0.001), heart (P < 0.0001) and
bone marrow (P < 0.0001) within seven days in all Mx-cre
THOC5/FMIP (flox/flox) mice. In contrast, in spleen,
intestine, testes and lung, the level is not reduced (Figure
2A and 2B).
Deletion of THOC5/FMIP gene causes death within two 
weeks
Since conventional knockout mice died at the embryonic
stage, we determined whether THOC5/FMIP is necessary
for postnatal mouse survival. We therefore injected three-
day-old mice (n = 25) with 50 μg of poly (I:C) three times
at two-to-three-day intervals. Mx-cre THOC5/FMIP(flox/
flox) mice began dying three days after injection and then
all died within 14 days after the first injection, whereas all
control mice (THOC5/FMIP(flox/flox)) survived (Figure
3A). We then injected 500 μg of poly (I:C) into nine-week-
old mice (n = 7) three times over a two-to-three-day inter-
val. These mice began dying eight days after the first poly
(I:C) injection and all of them were dead within 14 days
(Figure 3B), indicating that THOC5/FMIP gene expression
is essential for the survival of adult mice.
To determine the pathology underlying gene knockout-
induced death we analyzed specific organs and deter-
mined the weight of body, liver and spleen of five to six-
week-old Mx-cre THOC5/FMIP (flox/flox) (n = 9) and
THOC5/FMIP (flox/flox) (n = 6) mice before and after
three times 250 μg poly (I:C) treatment. No significant
differences were found in the weight of body or liver
between poly (I:C)-treated and -untreated mice or
between Mx-cre THOC5/FMIP (flox/flox) and control
THOC5/FMIP(flox/flox) mice seven days after poly (I:C)
injection (Figure 4A and 4B). Although there was no
depression of THOC5/FMIP expression level, within
seven days spleen weight of all Mx-cre THOC5/FMIP
(flox/flox) mice dropped to 50% (P = 0.0002) of that in
non-treated or control mice (Figure 4A). We next exam-
ined the histopathology of organs from the same mice
(seven days after poly (I:C) injection), including, liver,
heart, spleen and kidney.
Although white and red pulp in spleen are clearly present,
periarterial lymphoid sheath (PALs) which includes the T-
cell cuffs around the arteries and B-cell follicles appear to
be reduced in favor of a parafollicular lymphocytic popu-
lation which is interspersed more evenly in the red pulp.
Throughout the organ, there are a few spots of prolifera-
tively activated lymphoid cells (Figure 4C). Immunohis-
tochemical staining using the cleaved caspase 3 specific
antibody revealed that there were clearly more cleaved
caspase 3 positive cells in clusters underneath the capsule
(but not in the lymphoid follicles or PALs) in Mx-cre
THOC5/FMIP (flox/flox) spleen than in control spleen
(Figure 4C and 4D). In addition, no cleaved caspase 3
positive cells were observed in the red pulp, suggesting
that some subpopulation of lymphocytic cells may be
affected. Furthermore, liver, heart, and kidney, from
THOC5/FMIP depleted mice were histologically normal
throughout a 13 day period after poly (I:C) injection.
Although the liver looked pale in these mice, no abnor-
malities were observed and no cleaved caspase 3 positive
cells were seen in this organ (Figure 4D), suggesting that
THOC5/FMIP depleted mice may have anemia, and/or
internal bleeding.
Given the association of spleen with hematopoietic cells
we then examined peripheral blood and bone marrow.
THOC5/FMIP deletion causes severe leukocytopenia and 
anemia
Blood was taken from the tail vein of five-to-six-week old
Mx-cre THOC5/FMIP (flox/flox) (n = 9) and THOC5/
FMIP (flox/flox) (n = 6) mice on 0 (no poly I:C), four (2
× 250 μg (poly I:C)), seven (3 × 250 μg poly(I:C)), and 10
to 13 days (3 × 250 μg poly(I:C)) and examined. In agree-
ment with previous reports, poly (I:C) injection induces
slight leukocytopenia and thrombocytopenia in control
mice within four days [22-24], however 10 to 13 days after
poly (I:C) treatment, the number of leukocytes and plate-
lets in control mice returned to normal (Figure 5). InBMC Biology 2010, 8:1 http://www.biomedcentral.com/1741-7007/8/1
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THOC5/FMIP depleted mice, the number of leukocytes
and platelets continued to decrease. After seven days,
peripheral blood from most of the mice contained platelet
numbers less than 40 × 103/mm3, 13% (P = 0.02) of that
seen in control mice after injection of poly (I:C). Simulta-
neously, we observed subdermal bleeding in these mice
and within 13 days after the first poly (I:C) injection, all
mice showed a further reduction of leukocytes and plate-
lets (Figure 5). In addition, the erythrocyte count, hemo-
globin and hematocrit levels went down to 2 to 4 × 106/
mm3 (P = 0.01), 3-7 g/dl (P = 0.01), 13% (P = 0.01),
respectively, suggesting that THOC5/FMIP depleted mice
died from hematological disorders such as anemia, and
internal bleeding. These data also agree with the observa-
tion that liver and spleen in THOC5/FMIP deleted mice
appear pale.
Depression of THOC5/FMIP gene causes cell apoptosis in 
bone marrow, but not of hepatocytes
As severe leukocytopenia and anemia were observed in
THOC5/FMIP depleted mice, we examined the bone mar-
row cells after induced depletion of THOC5/FMIP pro-
tein. Bone marrow cells from five to six-week-old mice
were flushed from femora zero, four or seven days after
the first 250 μg poly (I:C) injection (n = 9). Cytospin prep-
arations were stained by May Grunwald solution and
hematoxylin. Although after four days we did not detect
any difference in morphology of bone marrow cells, after
seven days it became apparent that few hematoxylin-
stained cells were present in samples from Mx-cre
THOC5/FMIP(flox/flox) mice (Figure 6A). A high propor-
tion of those cells that were present showed dense chro-
matin staining, reminiscent of apoptotic cells. To examine
whether the cells that survived were apoptotic more than
2,000 4', 6-Diamidino-2-phenyindole (DAPI) positive
bone marrow cells were co-stained with terminal deoxy-
nucleotidyl transferase-mediated dUTP nick end labeling
(TUNEL) and DAPI for each preparation. Two and four
percent respectively of DAPI positive bone marrow cells in
control THOC5/FMIP(flox/flox) mice are stained with
TUNEL in the presence or in the absence of poly (I:C)
treatment (Figure 6B). In Mx-cre THOC5/FMIP(flox/flox)
mice, 15% of bone marrow cells are stained without
poly(I:C) injection, possibly as a result of the natural pres-
ence of interferons. After three poly (I:C) injections, only
a few DAPI positive cells are left and all remaining cells
were stained with TUNEL (Figure 6B), suggesting that
deletion of THOC5/FMIP causes bone marrow cell apop-
tosis. Furthermore, no significant increase of TUNEL pos-
itive cells (10-20%) was observed, suggesting that
apoptotic cells may fail to stay in bone marrow or be
phagocytosed. DNA laddering, indicative of apoptosis, in
bone marrow cells and hepatocytes was also examined.
We detected DNA fragmentation associated with apopto-
sis from the poly (I:C) injected bone marrow cells, but not
from the liver of the same mouse (Figure 6C).
Many erythrocytes are still present in bone marrow after
seven days. Given their extended lifetime compared to
white cells it is probable that the steady decrease in their
numbers is due to decreased rates of blood cell produc-
tion in the marrow.
The half life of erythrocytes in mice is about 18 days
[25,26]. The extent of the effect we observe (of about a
40% reduction over 10-13 days) argues for dysfunctional
erythropoiesis as the causal effect. However both white
cell and red cell numbers are depleted. Therefore the
lesion leading to death may be associated with hemat-
opoiesis.
THOC5/FMIP expression is reduced in specific organs Figure 2
THOC5/FMIP expression is reduced in specific 
organs. (A, B) 250 μg of poly (I:C) were injected into six-
week-old Mx-cre THOC5/FMIP (flox/flox) (n = 8) or control 
THOC5/FMIP (flox/flox) (n = 6) mice three times at two-to-
three-day intervals. THOC5/FMIP protein levels in liver, 
bone marrow, spleen (A), testicles, lung, kidney, large intes-
tine, and heart (B) were examined by THOC5/FMIP specific 
immunoblotting. Proteins were extracted from each organ. 
Total protein amount was standardized by actin specific 
immunoblotting.BMC Biology 2010, 8:1 http://www.biomedcentral.com/1741-7007/8/1
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Hematopoietic progenitor cell populations are depleted 
upon THOC5/FMIP deletion
The marrow hypoplasia observed in Mx-cre THOC5/FMIP
(flox/flox) mice after poly (I:C) injection led us to con-
sider the effects on hematopoietic progenitor cells and a
population enriched for primitive hematopoietic cells
including long-term reconstituting cells. To examine
hematopoietic progenitor cells, bone marrow cells were
isolated from mice four days after poly (I:C) injection.
Since we could obtained more consistent data from mice
treated with 2 × 500 μg than mice treated with 2 × 250 μg
at this time point, we injected five to six-week-old Mx-cre
THOC5/FMIP (flox/flox) (n = 5) and THOC5/FMIP (flox/
flox) (n = 6) mice with (2 × 500 μg (poly I:C) at a two-day
interval) in this experiment.
First we determined femoral cellularity which was found
to be depressed in Mx-cre THOC5/FMIP (flox/flox) mice
treated with poly (I:C) (Figure 7A). The same samples
were then taken for assessment of primitive hematopoi-
etic cell numbers. We determined the total number of cells
which were not expressing lineage markers for mature
hematopoietic cells, a measure of progenitor cells present
in the marrow. The Lin- cells were depleted to a greater
extent in THOC5/FMIP depleted animals than in control
animals (Figure 7B). We therefore assessed multipotent
colony forming cell numbers in soft gel assays. We could
detect no GEMM-CFU (granulocyte, erythrocyte, mono-
cyte, macrophage-colony forming unit) (which includes
early erythroid progenitors, see below) in THOC5/FMIP
depleted murine femora whilst they were present in both
control populations assayed. Similarly, granulocyte mac-
rophage colony forming cells (GM-CFU) were undetecta-
ble in THOC5/FMIP depleted bone marrow but were
present in control femora (Figure 7C). The effect of poly
(I:C) injection in Mx-cre THOC5/FMIP(flox/flox) mice on
primitive multipotent colony forming cells, GEMM-CFU,
and GM-CFU is therefore a profound reduction. Further-
more, an analysis of the Lineage marker depleted, Sca+,
Kit+  (LSK) cell numbers present in the bone marrow
revealed that the proportion of LSK cells (which co-enrich
with primitive hematopoietic cells and include long term
reconstituting cells) was not substantially changed when
Mx-cre THOC5/FMIP(flox/flox) mice were treated with
poly (I:C). However the total number of these cells per
femur was decreased by 80% per femur. This argues for
primitive hematopoietic cells as well as lineage specific
progenitor cells being depleted as a consequence of
THOC5/FMIP knockout.
As detailed the Lineage marker negative cell population,
generally considered a progenitor cell cohort, was reduced
by 92% by poly (I:C) treatment of Mx-cre THOC5/
FMIP(flox/flox) mice (Figure 7B) and myeloid progeni-
tors are decreased. Furthermore, lineage marker depleted
Sca- Kit+ cell population which consists largely of eryth-
roid progenitors [27] was also decreased by 98% (Figure
7F). We envisage the stem cell compartment is apparently
radically but slightly less affected (74% decrease, Figure
7E) as it turns over more slowly than rapidly cycling pro-
genitor cell populations. These data are consistent with a
failure of hematopoiesis in the stem cell and progenitor
cell compartments as a result of FMIP levels falling in
hematopoietic cells.
A transfer of normal bone marrow cells rescued 70% of 
mice from death by THOC5/FMIP depletion
Although THOC5/FMIP was depleted in liver, kidney,
heart and bone marrow, the only evident phenotype alter-
ation was observed in bone marrow cells. It may be
explained that THOC5/FMIP depletion displays a pheno-
Deletion of THOC5/FMIP is lethal in adult mice Figure 3
Deletion of THOC5/FMIP is lethal in adult mice. 
Three day- (n = 25) (A) and nine-week-old (n = 7) (B) mice 
were injected with 50, and 500 μg of poly (I:C), respectively. 
Injection was performed i.p. three times at two to three day 
intervals. (arrows: poly (I:C) injection).BMC Biology 2010, 8:1 http://www.biomedcentral.com/1741-7007/8/1
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THOC5/FMIP deletion causes reduction of spleen size and induction of cleaved caspase 3 Figure 4
THOC5/FMIP deletion causes reduction of spleen size and induction of cleaved caspase 3. Two hundred and fifty 
micrograms of poly (I:C) were injected into six-week-old Mx-cre THOC5/FMIP (flox/flox) (n = 9) or control THOC5/FMIP 
(flox/flox) (n = 6) mice three times at two-to-three-day intervals. (A) Weight of body, liver, spleen and heart. (B) Macrogra-
phy of liver and spleen: seven days after the first poly (I:C) treatment. Mx-cre -: control mice (THOC5/FMIP (flox/flox)); Mx-
cre +: THOC5/FMIP depleted mice (Mx-cre THOC5/FMIP (flox/flox)). (C, D) Seven days after the first poly (I:C) injection 
(3×), mouse spleens, heart, liver were fixed in formalin. Paraffin sections were stained by hematoxylin and eosin (C). Spleen 
and liver sections were supplied for immunohitochemical staining using cleaved caspase 3 (D). Original magnification: ×100 for 
C and ×200 for D.BMC Biology 2010, 8:1 http://www.biomedcentral.com/1741-7007/8/1
Page 8 of 17
(page number not for citation purposes)
type first in this fast turnover tissue that is very dependent
on stem cell self-renewal and differentiation. Hematopoi-
etic cells especially white cells such as neutrophils turn
over rapidly, and it is in keeping with observations on the
sensitivity of hematopoiesis insult such as irradiation or
cytotoxic drugs that the first major signs of THOC5/FMIP
removal are observed in bone marrow derived cells. The
question rose as to whether other organs, such as liver,
kidney and heart would have shown pathological altera-
tions if the mice had survived for longer periods. There-
fore, we examined next whether a transfer of normal bone
marrow cells rescues THOC5/FMIP depleted mice. We
transferred 106 bone marrow cells derived from THOC5/
FMIP(flox/flox) mice into nonablated Mx-cre THOC5/
FMIP(flox/flox) mice via i.v. and a day after transplanta-
tion we injected recipient mice with poly (I:C), followed
by two additional injections. Nine out of 14 mice survived
longer than two months and no symptoms were observed
(Figure 8A). Furthermore, the exon IV/V of THOC5/FMIP
gene was deleted completely from liver genomic DNA of
survivors (data not shown), indicating that cre-recombi-
nase was expressed by poly (I:C) injection in liver.
Although THOC5/FMIP expression was drastically down-
regulated in the livers of survivors, histological abnormal-
ities were not observed in liver, kidney and heart. Cyt-
ospin preparations revealed that only few hematoxylin-
stained cells were present in samples from four bone-mar-
row-recipient mice which died (Figure 8B, Non-survivor),
while normal populations of hematoxylin-stained cells
with few apoptotic cells were present in samples from sur-
vivors (Figure 8B, Survivor). The phenotype of the non-
survivors is identical (leukocytopenia, anemia, bleeding,
the reduced size spleen, and so on.) to that of non-recipi-
ent mice, suggesting that bone marrow transplantation
did not work in these mice. It may be related to the fact
that the bone marrow cell transplantation was performed
into nonablated mice. In some case, there may be no open
space for donor cells [28]. Another possibility is that each
Mx-Cre FMIP flox/flox mouse has a slightly different
strain background, suggesting that in some cases, a graft-
versus-host reaction may occur.
All bone marrow cell recipient mice showed extramedul-
lary hematopoiesis in spleen, but no significant patholog-
ical change was observed in other organs. These data
suggest that THOC5/FMIP is required in bone marrow for
hematopoiesis, however THOC5/FMIP is less important
in other organs, such as liver and heart.
Deletion of THOC5/FMIP results in markedly decreased 
THOC1
We have recently shown that the C-terminal domain of
THOC5/FMIP forms a complex with THOC1 and the N-
terminal domain binds to THOC7 directly [19]. Further-
more, the binding of THOC7 to THOC5/FMIP requires
The effect of deletion of THOC5/FMIP on hematopoiesis Figure 5
The effect of deletion of THOC5/FMIP on hemat-
opoiesis. Six-week-old Mx-cre THOC5/FMIP (flox/flox) 
mice (Mx cre +, n = 9) and THOC5/FMIP (flox/flox) mice 
(Mx-cre -, n = 6) were injected with poly (I:C) (250 μg each) 
and blood was taken from the tail vein on zero, four and 
seven days after the first poly (I:C) injection. In addition, 10-
13 days after poly (I:C) injection blood samples from Mx-cre 
THOC5/FMIP (flox/flox) mice (n = 3) which show severe 
symptom and control THOC5/FMIP (flox/flox) (n = 3) mice 
were taken from tails. Samples were analyzed on an ABC Vet 
automated blood counter. Wbc = white blood cells (103/
mm3); Plt = platelets (103/mm3); Rbc = red blood cells (106/
mm3); Hgb = hemoglobin (g/dl); Hct = hematocrit (%).BMC Biology 2010, 8:1 http://www.biomedcentral.com/1741-7007/8/1
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the nuclear localization of THOC7. These facts raise the
question as to whether loss of THOC5/FMIP molecule
influences stability of another member of the complex.
Since THOC5/FMIP expression was drastically down-reg-
ulated in the livers, we analyzed the expression of the
members of the THO complex in liver tissue before and
after poly (I:C) injection. Fourteen days after poly (I:C)
injection, there was more than an 80% decrease of
THOC5/FMIP observed at the protein level. Although Aly,
and THOC6 were unchanged, the amount of THOC1
went down to 30% within 14 days (Figure 9A). A reduced
level of THOC1 was also observed in THOC5/FMIP
depleted bone marrow cells (Figure 9B). Furthermore, a
broad band with molecular mass of 60 kDa was detected
from poly (I:C) treated liver and bone marrow cell extract
by THOC1 specific immunoblot analysis (Figure 9B), sug-
gesting that THOC1 protein may not be stable in the
absence of THOC5/FMIP. To examine whether THOC1
decreases at the mRNA level, we performed RT-PCR in
these organs. Using THOC5/FMIP specific primers 643 bp
product was obtained from untreated liver mRNA, while
a 431 bp product was obtained from poly (I:C) treated
liver mRNA (Figure 9C). The difference in size corre-
sponds to the exon IV/V deletion in treated animals. The
mRNA levels of THOC1 and Aly were unchanged by treat-
ment with poly (I:C). To confirm these data without poly
(I:C) effect, we utilized mouse embryo fibroblasts (MEF)
isolated from THOC5/FMIP (flox/flox) mice. After infec-
tion with adenovirus carrying GFP and cre-recombinase,
THOC5/FMIP was drastically reduced within four days. In
agreement with data obtained from liver tissue, the level
of THOC1 protein was also drastically reduced (Figure
9D). As control we infected adenovirus carrying GFP
alone. We did not observe a reduction of THOC5/FMIP or
THOC1 in control virus infected MEF. These data suggest
that depletion of THOC5/FMIP causes down regulation of
THOC1 also in cell culture system.
Our data indicate that THO complex plays a key role in
early embryogenesis and the THO complex in bone mar-
row is essential for hematopoiesis, however it is less
important in differentiated cell types such as hepatocytes
and heart muscles.
Discussion
We have previously shown that depletion of THOC5/
FMIP by siRNA or ectopic expression causes abnormal
hematopoiesis and abnormal adipocyte differentiation in
myloid progenitor or mesenchymal progenitor cell lines
[14-17]. Furthermore, although THO complex does not
play a role in nuclear export of bulk mRNA, THOC1 dele-
tion causes embryonic lethality [13]. This led us to inves-
tigate the potential roles for THOC5/FMIP in vivo. To do
this we first generated conventional knockout mice, delet-
ing THOC5/FMIP. These mice died at an early embryonic
stage. Furthermore, although heterozygotic THOC5/FMIP
deletion mutant mice were fertile and did not display any
phenotypic or histological abnormalities after birth, 50%
of THOC5/FMIP heterozygotes died during embryogene-
sis (El Bounkari and Tamura, unpublished data), suggest-
ing that the level of expression of THOC5/FMIP plays a
key role in embryo development.
When an inducible system was developed a key develop-
mental system, hematopoiesis, was found to be sensitive
to depletion of THOC5/FMIP. Our data showed that bone
marrow cells and spleen cells, but no other organs, such as
liver, heart, kidney, intestine, testicle, or lung, became
apoptotic in THOC5/FMIP deficient adult mice, suggest-
ing hematopoietic required THOC5/FMIP. In addition,
transplantation with bone marrow cells derived from cre
minus THOC5/FMIP(flox/flox) mice rescues poly (I:C)
injected Mx-cre THOC5/FMIP(flox/flox) mice from death.
This extends back to the primitive cells in the hematopoi-
etic system, since THOC5/FMIP depleted mice showed a
major decrease in progenitor cells (GEMM-CFU, GM-
CFU, Figure 7C) and also a fall in the slowly cycling bone
marrow LSK cells (Figure 7D). The effects of an RNA
processing protein on stem cells were also profound and
this we argue in part explains the massive effect on the
committed progenitor cell compartment compared to LSK
cells. Nonetheless, the rapid onset of the effect also argues
that the progenitor cell compartment is sensitive to loss of
FMIP/THOC5 expression.
Mx-cre directed depletion by poly I:C injection was
observed in bone marrow cells, heart, kidney, liver and
spleen [21,29]. Indeed, THOC5/FMIP specific PCR analy-
ses using genomic DNA as a template revealed that exons
IV/V were deleted from these organs, including spleen
after only one × times poly (I:C) injection. We did not
observe the depletion of THOC5/FMIP protein in spleen
for any time period however, the size of spleen is drasti-
cally reduced after seven days poly (I:C) injection, suggest-
ing that apoptotic cells are released from spleen and that
the THOC5/FMIP protein half life in certain cells was
longer than in other cells.
The issue remains how and why THOC5/FMIP is required
for primitive hematopoietic as well as embryo stem cell
survival and/or proliferation. Our data suggest that the
THO complex is required for mRNA export of particular
genes that play a key role in hematopoietic primitive
(multipotent) and committed progenitor cell survival
and/or proliferation. Alternatively, the THO complex may
be essential for bulk poly (A)+ RNA export in primitive
cells. The yeast TREX complex is composed of the THO
transcription elongation complex (Hpr1 (the THOC1
orthologue), Tho2 (the THOC2 orthologue), Mht1 and
Thp2), Tex1 (the THOC3 orthologue), Sub2 (the UAP56BMC Biology 2010, 8:1 http://www.biomedcentral.com/1741-7007/8/1
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Deletion of THOC5/FMIP causes apoptosis of leukocytes in bone marrow Figure 6
Deletion of THOC5/FMIP causes apoptosis of leukocytes in bone marrow. Six-week-old Mx-cre THOC5/FMIP (flox/
flox) mice (n = 9) and THOC5/FMIP (flox/flox) control mice (n = 6) were injected with poly (I:C) (250 μg each) and the femora 
were then isolated. (A): Bone marrow cells were spun down onto glass slides and then stained with May-Grunwald Giemsa 
and hematoxylin. (B): Aliquots of same preparation were stained with TUNEL and DAPI. Results are the mean +/- SEM of 
%TUNEL positive/DAPI positive cells (n >2000 cells). Original magnification: ×200 for all panels. (C): Aliquots of 2-3 μg of 
DNA from liver and bone marrow of poly (I:C) treated (+) and untreated (-) Mx-cre THOC5/FMIP (flox/flox) mice were sepa-
rated on 1.5% (w/v) agarose gel, stained with ethidium bromide (2 μg/ml) and photographed under UV light. M: base pair 
Marker.BMC Biology 2010, 8:1 http://www.biomedcentral.com/1741-7007/8/1
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Deletion of THOC5/FMIP causes loss of primitive hematopoietic cells from the bone marrow Figure 7
Deletion of THOC5/FMIP causes loss of primitive hematopoietic cells from the bone marrow. Five-to-six-week-
old Mx-cre THOC5/FMIP (flox/flox) (n = 5) and THOC5/FMIP (flox/flox) (n = 6) mice were injected with poly (I:C) (2 × 500 
μg, two days interval). Then, bone marrow cells were isolated from mice four days after poly (I:C) injection. The effect of 
THOC5/FMIP depletion on the total numbers of primitive cells present in the bone marrow was assessed using a number of 
different approaches (A; B): total bone marrow cellularity per femur was assessed (A) and the number of cells present in the 
bone marrow which do not express lineage markers (B) (and therefore have a primitive phenotype) was calculated (Mean+/-
SEM). Results shown are for Mx-cre THOC5/FMIP (flox/flox) (Mx-CreFMIPf/f) mice with (n = 5) and without (n = 4) poly (I:C) 
(2 × 500 μg, two day interval), and THOC5/FMIP (flox/flox) (FMIPf/f) control mice with (n = 6) and without (n = 6) Poly (I:C) 
(2 × 500 μg, two day interval) (C). The number of colony forming cells per femur was determined for Colony Forming Unit-
Granulocyte macrophage (GM-CFU) and Colony Forming Unit-Granulocyte Erythroid Macrophage Megakaryocyte (GEMM-
CFU). Results shown are the mean+/-SEM, n = 3. (D): Flow cytometric profile of Kit and Sca staining in Lineage marker 
depleted cells from mice treated with and without poly (I:C) (3 × 250 μg, two day interval). The results shown are representa-
tive of six experiments. (E; F) Results shown are for Mx-cre THOC5/FMIP (flox/flox) mice with (n = 5) and without (n = 4) 
poly (I:C) (2 × 500 μg, two day interval), and THOC5/FMIP (flox/flox) control mice with (n = 6) and without (n = 6) poly (I:C) 
(2 × 500 μg, two-day-interval), and are expressed as total number of LSK cells (E) and Lin-Sca-Kit+ cells (LS-K+) cells (F) per 
femur, error bars show SEM.BMC Biology 2010, 8:1 http://www.biomedcentral.com/1741-7007/8/1
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orthologue) and Yra1 (the Aly/THOC4 orthologue) [30].
Yeast TREX mutants show a nuclear export defect for bulk
poly A+ RNAs and are synthetically lethal with many
mutants of the mRNA machinery [30]. In Drosophila loss
of the THO complex function results in only minor differ-
ences in transcription profiles as revealed by the whole
genome array [5]. The analysis of the cytoplasmic mRNA
from bone marrow cells was not successful, because cyto-
plasmic mRNA from bone marrow cells was not stable
enough for microarray analysis. Therefore, we analyzed
the expression level of cytoplasmic mRNA in fibroblasts.
In the presence or absence of THOC5/FMIP, we found
that less than 100 genes were down-regulated more than
three-fold using the mouse whole genome array (Hauser
and Tamura, unpublished data). In the fibroblast system,
however, the depletion of THOC5/FMIP did not cause
apoptosis, but reduced cell growth (Tran and Tamura,
unpublished data), suggesting that THOC5/FMIP has a
specific function in proliferating cells. It has been shown
recently that in response to treatment of mice with inter-
feron-alpha hematopoietic stem cells efficiently exit G0
and enter an active cell cycle [31], suggesting that poly
(I:C) treatment may exacerbate the phenotype which is
observed in THOC5/FMIP deletion mice. Further studies
will be required to examine whether the mice would
present the same phenotype if other methods of condi-
tional deletion of THOC5/FMIP in the relevant cell types
were used.
We show here that the THOC5/FMIP binding partner,
THOC1 was down-regulated via THOC5/FMIP knock-
down. Furthermore, we have shown that the expression of
mutant THOC5/FMIP lacking the THOC1 binding site
degraded faster than the wild-type and down-regulated
the level of endogenous THOC1 [19], suggesting that
these two molecules may stabilize each other forming a
functional unit. It indicates that the phenotype we
observed might be the result of both THOC1 and THOC5/
FMIP depletion. It has been shown that over-expression of
THOC1 causes apoptosis in several cells [12]. The dele-
tion of THOC1 also causes apoptosis in cancer cells, but
not in normal fibroblasts [12]. Furthermore, the embry-
onic development of conventional THOC1 knockout
mice is arrested around the time of implantation [13].
Interestingly, THOC1 possesses the death domain and
interacts with Rb protein, suggesting that THOC1 may
involve the apoptosis signal directly [32].
Our analysis demonstrates a link between THOC5/FMIP
protein function and the normal developmental processes
seen in adult hematopoiesis. We now have a suitable
model system to determine how THO complex proteins
act, enabling primitive cell survival and proliferation.
Conclusions
THOC5/Fms interacting protein is an essential element in
the maintenance of hematopoiesis. Furthermore, mecha-
nistically depletion of THOC5/Fms interacting protein
causes the down-regulation of its direct interacting part-
ner, THOC1 which may contribute to altered THO com-
plex function and cell death.
Methods
Generation of THOC5/FMIP deficient mice
THOC5/FMIP deficient mice were generated using a
genomic DNA fragment containing exons II, III and IV,
isolated from a 129/ola genetic background. The targeting
vector was constructed from a 3.9 kb PCR fragment and an
adjacent 2.2 kb fragment harboring exons IV/V. Fragments
were introduced into the pPNTloxPneo vector via NotI,
XhoI restriction sites and KpnI, respectively. An additional
loxP site was inserted into the SacI site downstream of
exon V (Figure 1A). ES cells were electroporated with a
NotI linearized target vector and grown under double
selection as previously described [33]. ES cell clones carry-
ing the inserted floxed neo cassette and floxed THOC5/
FMIP exons IV/V were identified by the presence of an 1.9
kb BamHI restriction fragment in Southern Blot analysis
with an external 3' probe (Figure 1B). One clone was used
for injection into C57Bl/6 blastocysts to generate germ
line chimeras. Chimeras were mated with wild type mice
to obtain heterozygous floxed offspring.
Genotyping for THOC5/FMIP (flox/flox) and Mx-cre 
THOC5/FMIP (flox/flox) mic
Genotyping was performed from tail-derived sample
DNA extracted with Viagen DirectPCR-Tail (Viagen, Erlan-
gen, Germany) by PCR. THOC5/FMIP primers flanked the
floxed region with 5'-CCCTCGGCCCCTTTTGAG-3' and
5'-CAGCACTGGAGCGGGAGATGT-3'. Corresponding
bands gave 177 bp (wt allele) and 210 bp sizes (floxed
allele), respectively. Homozygous offspring were inter-
bred to generate THOC5/FMIP(flox/flox) mice and the
resulting genotypes were determined by PCR. After cross-
ing with Mx-cre deleter mice, mice were genotyped by
PCR using primers Cre1 5'-CCGGGCTGCCACGACCAA-
3' and Cre2 5'-GGCGCGGCAACACCATTTT-3' for cre
gene and primers for floxed THOC5/FMIP gene. After
poly (I:C) injection, mice were genotyped by PCR using
primers 5'-TGCTGGCATTGAACTGTG-3' and 5'-CAG-
CACTGGAGCGGGAGATGT-3' for the determination of
exons IV/V deletion.
RT-PCR analysis
RNA was isolated from mouse liver tissue with the Qiagen
RNeasy kit (Qiagen, Hilden, Germany) according to the
manufacturer's recommendations. Reverse transcription
was carried using oligo dT primers and Omniscript reverseBMC Biology 2010, 8:1 http://www.biomedcentral.com/1741-7007/8/1
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Bone marrow transplantation rescues THOC5/FMIP depleted mice from death Figure 8
Bone marrow transplantation rescues THOC5/FMIP depleted mice from death. (A) Bone marrow (BM) transplan-
tation: 106 bone marrow cells obtained from THOC5/FMIP (flox/flox) mice (n = 14) were transferred into six-to-eight-week-
old nonablated Mx-cre THOC5/FMIP (flox/flox) mouse for each and one day after transplantation recipient mice were injected 
with 250 μg of poly (I:C). Injection was performed i.p. three times at two-to-three-day intervals. No transplantation: Mx-cre 
THOC5/FMIP (flox/flox) mice without BM transplantation were injected with poly (I:C). (B) Bone marrow cells were spun 
down onto glass slides and then stained with May-Grunwald Giemsa and hematoxylin. Bone marrow cells were derived from 1) 
non-treated Mx-cre THOC5/FMIP (flox/flox) mouse. 2) a poly (I:C) injected normal bone marrow cell recipient Mx-cre 
THOC5/FMIP (flox/flox) mouse which died 18 days after the first injection (Nonsurvivor). 3) a poly (I:C) injected normal bone 
marrow cell recipient Mx-cre THOC5/FMIP (flox/flox) survivor (eight weeks after the first injection) (Survivor).BMC Biology 2010, 8:1 http://www.biomedcentral.com/1741-7007/8/1
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Depletion of THOC5/FMIP causes down-regulation of THOC1 Figure 9
Depletion of THOC5/FMIP causes down-regulation of THOC1. (A): Liver extracts from three times poly (I:C) 250 μg 
treated (+) (14 days) and untreated (-) six-week-old Mx-cre THOC5/FMIP (flox/flox) mice (n = 3) were examined by THOC1, 
Aly, THOC6, THOC5/FMIP, Actin and Histone H3 specific immunoblotting. Each sample consisted of 100 μg of liver. (B): Liver 
or bone marrow extracts from poly (I:C) treated (+) (14 days) were examined by THOC1, THOC5/FMIP, and actin specific 
immunoblotting. THOC1*: 60 kDa THOC1 degradation product from poly (I:C) treated liver or bone marrow sample. (C): 
mRNA was isolated from the same liver samples and THOC5/FMIP (643 bp and 431 bp (without exons IV/V)), THOC1 (258 
bp), Aly (420 bp) and Actin (509 bp) specific RT-PCR were performed. (D): MEF THOC5/FMIP (flox/flox) cells were infected 
with adenovirus carrying GFP gene (Ad-GFP) or adenovirus carrying GFP and cre-recombinase genes (Ad-GFP-Cre) (M.O.I. 
50; Vector Biolab, Philadelphia, PA, USA) then lysed by laemmli buffer. Extracts were then examined by THOC1, Aly, THOC6, 
THOC5/FMIP, GAPDH and Histone H3 specific immunoblotting.BMC Biology 2010, 8:1 http://www.biomedcentral.com/1741-7007/8/1
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transcriptase kit (Qiagen) following the instructions pro-
vided. For PCR the following primer pairs were used:
THOC1: forward primer: 5'-CTCACTTCTTCAGCCAA CC-
3'; reverse primer: 5'-AAGGAGCCAAAATCTTCCAT-3'
(product size = 258 bp), Aly: forward primer: 5'-
CTGGACTTCGGAGTGTCAGATGC-3'; reverse primer: 5'-
CCTTGCATTGTA AGCATCCAGC-3' (product size = 420
bp), THOC5/FMIP: forward primer: 5'-TCT GCCTTT-
TCACCTGGAAG-3'; reverse primer: 5'-CTCGGTACTTT-
TCTGCCA GC-3' (product size = 643 bp (wild type), or
431 bp (without exons IV/V)), beta-actin forward primer:
5'-AACACCCCAGCCATGTACGTAG-3'; reverse primer: 5'-
GTGTTGGCATAGAGGTCTTTACGG-3' (product size =
509 bp). PCRs were set up according to the following pro-
file: an initial denaturation step of 94°C for three min-
utes, 35 cycles of 94°C for 30 seconds, 60°C for 30
seconds, and 72°C for 30 seconds followed by a final
extension step at 72°C for 10 minutes. Separation of the
DNA fragments was carried out on 1.5% (w/v) agarose
gels, stained with ethidium bromide (2 μg/ml) and pho-
tographed under UV light.
Poly (I:C) injection
Fifty, 250 or 500 μg of poly(deoxyinosinic/deoxycyti-
dylic) acid (Invivogen, San Diego, CA, USA) were injected
intraperitoneally into three day-, six week- and nine week-
old mice respectively, three times at two-to-three-day
intervals.
Hematopoiesis assays
Cytospin preparations were generated from bone marrow
cells then visualized by May-Grunwald and Hematoxylin
stain. Peripheral blood was collected by means of tail ven-
ipuncture into microcapillary tubes pre-coated with ethyl-
enediamine tetraacetic acid. Samples were analyzed on an
ABC Vet automated blood counter (ABX Hematology Inc.
Garden Grove, CA, USA).
Hematopoietic lineage marker depleted (Lin-) cells were
obtained using a cocktail of lineage marker antibodies
(Pharmingen, Oxford, UK). Sheep anti-rat antibody mag-
netic beads (Dynal, Wirral, UK) were employed to deplete
cells expressing lineage markers. Lineage depleted cells
were then labeled with fluorescein isothiocyanate-
labelled Sca-1 antibody and with phycoerythrin labeled c-
Kit antibody (Becton Dickinson, Oxford, UK). The expres-
sion of Sca antigen and Kit antigen were employed to
define primitive cells present in the bone marrow using
flow cytometry with a Becton Dickinson FacsAria instru-
ment (Becton Dickinson, Oxford, UK) [34].
Colony forming assays were performed using soft gel
assays from Stem Cell Systems (Vancouver, BC. Canada)
following the manufacturer's instructions.
TUNEL, DAPI staining and DNA ladder
To assess the degree of apoptosis, an in situ cell death
detection kit (Roche, Mannheim, Germany) was used for
terminal deoxynucleotidyl transferase-mediated dUTP
nick end labeling (TUNEL) staining and 4',6-diamidino-
2-phenylindole (DAPI) (Sigma, Munich, Germany) was
used for control DNA staining. Genomic DNA was iso-
lated from liver and bone marrow cells from poly (I:C)
treated and untreated mice, using the DNeasy Tissue Kit
(Qiagen). Aliquots of 2 to 3 μg of DNA were separated on
1.5% (w/v) agarose, stained with ethidium bromide (2
μg/ml) and photographed under UV light.
Immunohistochemistry
Immunohistochemistry study was performed as detailed
previously [35].
Isolation of mouse embryo
Mouse embryos were isolated under the microscope
according to a protocol from Beckers et al. (2007) [36].
Western Blot procedures
Mouse organs were extracted with lysis buffer containing
10 mM Tris HCl pH 7.6, 50 mM NaF, 1 mM PMSF, 10 mM
EDTA, 1%(w/v) Triton-X 100, 8 M Urea, 1%(w/v) Trasylol
(Bayer Vital, Leverkusen, Germany). Details of immunob-
lotting have been described previously [37]. Polyclonal
antibody against actin, monoclonal antibodies against
Aly/THOC4, THOC6 and GAPDH were purchased from
Santa Cruz biotechnology inc.(Santa Cruz, CA, USA), rab-
bit antibodies against Histone H3 and cleaved caspase 3
were from Cell Signaling Technology (Beverly, MA, USA),
monoclonal antibody against THOC1 (p84 N5) was from
Gene Tex. Inc (San Antonio, TX, USA), monoclonal anti-
body against THOC5/FMIP was generated as described
previously [16]. Corresponding proteins were visualized
by incubation with peroxidase conjugated anti-goat,
mouse or rabbit immunoglobulin followed by incubation
with SuperSignal West FemtoMaximum Sensitivity Sub-
strate (Pierce, Rockford, IL, USA). Results were docu-
mented on a LAS3000 (Fujifilm, Kanagawa, Japan). Signal
intensity of chemoluminescence was quantified using
TINA 2.0 software (Raytest Isotopenmessgeraete GmbH,
Straubenhardt, Germany).
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